Title:
COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
Document Type and Number:
Japanese Patent JP2017214435
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide combination therapies for B-cell lymphomas which use treatment using anti-CD20 antibodies in combination with cytokines or with a radiotherapy, myeloablative therapy or chemotherapy.SOLUTION: A method for treating a relapsed B-cell lymphoma comprises administering a therapeutically effective amount of an anti-CD20 antibody to a patient having the relapsed B-cell lymphoma.SELECTED DRAWING: None
Inventors:
GRILLO-LOPEZ ANTONIO
Application Number:
JP2017178950A
Publication Date:
December 07, 2017
Filing Date:
September 19, 2017
Export Citation:
Assignee:
BIOGEN NV
International Classes:
A61K38/21; A61K31/4745; A61K39/395; A61K31/475; A61K31/569; A61K31/573; A61K31/675; A61K31/704; A61K38/00; A61K38/19; A61K38/20; A61K51/00; A61K51/10; A61L27/36; A61L27/38; A61P35/00; A61P35/04; A61P43/00; C02F1/00; C07K16/00; C07K16/28
Other References:
ONCOLOGY, vol. 12(12), JPN6017021163, December 1998 (1998-12-01), pages p.1763-1770,1775-1777,1781
PROCEEDINGS OF AMERICAN SOCIETY OF CLINICAL ONCOLOGY, vol. Vol.18, JPN6017021164, 12 July 1999 (1999-07-12), US, pages p.29a,abstract 105
PROCEEDINGS OF AMERICAN SOCIETY OF CLINICAL ONCOLOGY, vol. Vol.18, JPN6017021164, 12 July 1999 (1999-07-12), US, pages p.29a,abstract 105
ECOG COORDINATING CENTER, ACTIVATION OF PROTOCOL E1496, RANDOMIZED PHASE III STUDY IN LOW GRADE LYMPHOMA COMPARING CYCLOPHOSPH, vol. Ex1003, JPN6018031326, 19 March 1998 (1998-03-19), pages 1 - 47
PROCEEDINGS OF AMERICAN SOCIETY OF CLINICAL ONCOLOGY, vol. Vol.18, JPN6017021164, 12 July 1999 (1999-07-12), US, pages p.29a,abstract 105
PROCEEDINGS OF AMERICAN SOCIETY OF CLINICAL ONCOLOGY, vol. Vol.18, JPN6017021164, 12 July 1999 (1999-07-12), US, pages p.29a,abstract 105
ECOG COORDINATING CENTER, ACTIVATION OF PROTOCOL E1496, RANDOMIZED PHASE III STUDY IN LOW GRADE LYMPHOMA COMPARING CYCLOPHOSPH, vol. Ex1003, JPN6018031326, 19 March 1998 (1998-03-19), pages 1 - 47
Attorney, Agent or Firm:
Asamura patent office